D‐cycloserine‐augmented one‐session treatment of specific phobias in children and adolescents

BACKGROUND: D‐Cycloserine has potential to enhance exposure therapy outcomes. The current study presents a preliminary randomized, placebo‐controlled double‐blind pilot trial of DCS‐augmented one‐session treatment (OST) for youth (7–14 years) with specific phobia. A secondary aim of this pilot study...

Full description

Saved in:
Bibliographic Details
Published in:Brain Behav
Main Authors: Farrell, Lara J., Waters, Allison M., Oar, Ella L., Tiralongo, Evelin, Garbharran, Vinay, Alston‐Knox, Clair, McConnell, Harry, Collings, Nigel, Zimmer‐Gembeck, Melanie, Donovan, Caroline L., Testa, Chris, Storch, Eric A., Ollendick, Thomas H.
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5991588/
https://ncbi.nlm.nih.gov/pubmed/30106248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.984
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items